Clasto-Lactacystin β-lactone: Accelerating Translational ...
2025-10-18
This thought-leadership article explores the strategic deployment of Clasto-Lactacystin β-lactone, a potent, irreversible, and cell-permeable proteasome inhibitor, as a catalyst for translational breakthroughs in ubiquitin-proteasome pathway research. By integrating mechanistic insights, recent immunology findings, competitive landscape analysis, and actionable guidance, we highlight how this precision tool empowers researchers to decode complex cellular processes, model disease, and envision therapeutic innovation beyond conventional paradigms.